Plasma xantine oxidoreductase (XOR) activity in patients with acute myocardial infarction

Plasma xantine oxidoreductase (XOR) activity in patients with acute myocardial infarction - Acute myocardial infarction and plasma XOR activity

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022777

Enrollment

Registered

2016-06-17

Start date

2016-04-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patiets who admitted to our hospital diagnosed with acute myocardial infarction and emergent coronary intervention was performed. 2)Patients who give written informed consent.

Exclusion criteria

Exclusion criteria: 1)Patinets who the physician judged to be inappropriate to this study. 2)The patient who withdrew informed consent.

Design outcomes

Primary

Measure	Time frame
Relationships between plasma xantine oxidoreductase activity and prognosis in patients with acute myocardial infarction	—

Countries

Japan

Contacts

Public ContactHiroaki Yokoyama

Hirosaki University Graduate School of Medicine Department of Cardiology

hero8686@hirosaki-u.ac.jp0172-39-5057

Outcome results